We will begin today's call with Frank providing an overview of our business progress. Gerald will then cover the financials for the second quarter and first half of 2023 in more detail and share our updated fiscal year 2023 financial outlook. Now I'd like to turn the call over to Bruker's CEO, Frank Laukien. Thank you, Justin. Good morning, everyone and thank you for joining us on today's second quarter 2023 earnings call. While we acknowledge that general market conditions are becoming softer in more cycli ...

Bruker Corporation (NASDAQ:BRKR) Shareholder Analyst Call June 15, 2023 11:00 AM ET Company Participants Justin Ward - Senior Director of IR and Corporate Development Frank Laukien - Chairman, President and CEO Rohan Thakur - President, Life Sciences Mass Spectrometry Division Oliver Rinner - CEO of Biognosys Conference Call Participants Justin Ward Well, good morning. I would like to welcome everyone to Bruker Corporation's 2023 Investor Day. I'm Justin Ward, Senior Director of Investor Relations and Corp ...

On a quarterly basis, the Company reviews minority investments and equity method investments to determine if there have been any events and conditions that could indicate an impairment or other-than temporary impairment. In the three months ended March 31, 2023, the Company recognized $6.9 million of impairment charge in "Interest and other income (expense), net" in the Consolidated Statement of Operations, to write-off the costs of certain minority investments. No impairments were noted in the three months ...

Bruker Corporation (NASDAQ:BRKR) Q1 2023 Earnings Conference Call May 4, 2023 8:30 AM ET Justin Ward - Senior Director of IR & Corporate Development Frank Laukien - Chairman, President & CEO Gerald Herman - EVP & CFO John Sourbeer - UBS Puneet Souda - SVB Securities Josh Waldman - Cleveland Research Daniel Arias - Stifel Patrick Donnelly - Citi Rachel Vatnsdal - JPMorgan Jack Meehan - Nephron Daniel Brennan - Cowen Brandon Couillard - Jefferies Matt Sykes - Goldman Sachs Good day, and welcome to the Bruker ...

Bruker Corporation (NASDAQ:BRKR) Cowen 43rd Annual Health Care Conference March 6, 2023 2:10 PM ET Company Participants Gerald Herman - EVP & CFO Conference Call Participants Max Masucci - Cowen & Co. Max Masucci Well again, welcome to TD Cowen's 43rd Annual Health Care Conference. I'm Max Masucci, one of the Life Science and Diagnostic Tools analysts here. We are pleased to be joined today by Bruker, one of the three large cap names in our coverage. And a diversified participant in several of the tools, di ...

Bruker Corporation (NASDAQ:BRKR) 2023 Citi Healthcare Services, Medtech, Tools & HCIT Conference March 2, 2023 9:30 AM ET Company Participants Gerald Herman - EVP & CFO Conference Call Participants Patrick Donnelly - Citi Patrick Donnelly All right. We can look to get started. Thanks, everyone for being here. I'm Patrick Donnelly, the Tools and Diagnostics analyst here at Citi. Happy to have Gerald Herman, CFO of Bruker with us for this session. Gerald Herman Hello. Patrick Donnelly Gerald, thanks for bei ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to __________ Commission File Number 000-30833 Delaware 04-3110160 (State or other jurisdiction of Incorporation or organization) (I.R.S. Employer Identification No.) 40 Mann ...

Company Participants Conference Call Participants Operator Justin Ward Before we begin, I would like to reference Bruker's safe harbor statement which is shown on Slide 2 of the presentation. During this call, we will make forward-looking statements regarding future events and the financial and operational performance of the company that involve risks and uncertainties, including those related to elevated geopolitical and energy risk the COVID 19 pandemic, and supply chain logistics and inflation challenges ...

Bruker Corporation (NASDAQ:BRKR) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Justin Ward - Senior Director of Investor Relations & Corporate Development Frank Laukien - Chairman, President & Chief Executive Officer Gerald Herman - Executive Vice President & Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Patrick Donnelly - Citi Puneet Souda - SVB Securities Dan Arias - Stifel Josh Waldman - Cleveland Research Nisarg Shah - Bank of America Rach ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT of 1934 For the transition period from to Commission File Number 000-30833 BRUKER CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-3110160 (State or other jurisdiction of incorp ...